1. Home
  2. SM vs BIO Comparison

SM vs BIO Comparison

Compare SM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SM Energy Company

SM

SM Energy Company

HOLD

Current Price

$31.18

Market Cap

7.5B

Sector

Energy

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$304.88

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SM
BIO
Founded
1908
1952
Country
United States
United States
Employees
N/A
7450
Industry
Oil & Gas Production
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
8.0B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SM
BIO
Price
$31.18
$304.88
Analyst Decision
Buy
Buy
Analyst Count
12
4
Target Price
$34.36
$339.75
AVG Volume (30 Days)
3.8M
281.3K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,154,000,000.00
N/A
Revenue This Year
$129.01
$2.74
Revenue Next Year
$6.29
$3.20
P/E Ratio
N/A
$9.72
Revenue Growth
17.24
N/A
52 Week Low
$17.45
$236.73
52 Week High
$35.88
$343.12

Technical Indicators

Market Signals
Indicator
SM
BIO
Relative Strength Index (RSI) 61.16 59.55
Support Level $30.06 $291.87
Resistance Level $31.50 $310.67
Average True Range (ATR) 0.98 7.91
MACD 0.56 0.84
Stochastic Oscillator 97.07 97.36

Price Performance

Historical Comparison
SM
BIO

About SM SM Energy Company

SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: